Gamma vinyl GABA in the treatment of levodopa-induced dyskinesias in Parkinson's disease.
Turjanski
N
N
Lees
A J
AJ
D000612:4-Aminobutyrate Transaminase / Q000037:antagonists & inhibitors*; D000328:Adult; D000368:Aged; D000614:Aminocaproates / Q000009:adverse effects / Q000627:therapeutic use*; D002819:Chorea / Q000139:chemically induced / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy*; D006801:Humans; D007980:Levodopa / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D009460:Neurologic Examination / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy*; D020888:Vigabatrin
D000614:Aminocaproates; D007980:Levodopa; D000612:4-Aminobutyrate Transaminase; D020888:Vigabatrin